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Ménière`s disease is a frequent vestibular disease that 
occurs predominantly in the fourth decade of life. Diagnosis 
is mostly medical and is based on findings of vertigo, 
sensorineural hearing loss, tinnitus and aural fullness. Aim: To 
study the clinical findings of Ménière`s disease: age, duration 
of vertigo, tinnitus, hearing loss and aural fullness, and 
unilateral or bilateral involvement. Method: a retrospective 
study included 39 patients with a diagnosis of Ménière`s 
disease confirmed by electrocochleography, who were seen 
at a neuro-otology referral centre. Patients underwent a 
clinical examination, audiometry and bilateral transtympanic 
electrocochleography. Patients were separated into 2 groups: 
bilateral Ménière`s disease and unilateral Ménière`s disease. 
Results: The mean age was 42.9 years; 72.5% were female. 
Fluctuation of hearing loss occurred in 54.5% of cases, and 
65.7% had frequent attacks of vertigo. Bilateral disease was 
observed in 33.3%. The onset of the disease was earlier in 
the bilateral group (33.7 years) compared to the unilateral 
group (p= 0.0013). Duration of disease, tinnitus, hearing loss 
and aural fullness were similar between groups. Conclusion: 
Patients with bilateral Ménière`s disease had symptoms earlier 
than patients with unilateral disease. There was no difference 
between the groups in duration of disease and associated 
symptoms. 
Keywords: ménière`s disease, hydrops, hearing loss, vertigo, 
tinnitus.
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INTRODUCTION
Meniere’s disease was described by Prosper Méniè-
re, in 1861. It represents one of the most common vesti-
bular diseases, with a prevalence rate of 46 to 200 cases 
for every 100 thousand individuals1. There is no gender 
distribution difference and it usually starts on the fourth 
decade of life2.
Lymphatic hydrops (LH) is the pathological subs-
trate of Meniere’s disease, characterized by a distention 
of the endolymphatic space3.
Hydrops is associated with viral or bacterial infec-
tious processes, immunomediated diseases, abnormalities 
in temporal bone development, genetic predisposition, 
trauma, otospongiosis, and others4 -10.
Meniere’s disease diagnosis is essentially clinical in 
nature. It is characterized by recurrent and spontaneous 
vertigo spells, fluctuating sensorineural hearing loss, tin-
nitus and ear fullness11. In 1972, the hearing and balance 
committee of the American Academy of Otolaryngology 
and Head and Neck Surgery (AAO-HNS) defined the pa-
rameters for the clinical diagnosis of Meniere’s disease. 
In 1995, the AAO-HNS enhanced these criteria, making 
them simple and more easily applicable11. According to 
AAO-HNS criteria, individuals with 2 or more spontaneous 
vertigo spells, lasting for 20 minutes or more, with docu-
mented hearing loss in at least one occasion and tinnitus 
or ear fullness are clinically classified as having Meniere’s 
disease11. Diagnosis certainty is only possible by means of 
a post mortem study of the temporal bone12.
Electrocochleography is the most adequate test to 
aid in the diagnosis13,14. It is based on recording endoco-
chlear potentials, generated at the time of sound stimulus 
transduction. The most used potentials for this end are the 
summation potential (SP) and the action potential (AP) 15. 
The SP reflects the activity of hair cells and, consequently, 
non-linear movements (vibratory asymmetries) of the base 
membrane15-17. The AP portrays the summation of nume-
rous action potentials in the neurofibril, which make up 
the auditory branch of the eighth cranial nerve15-17.
The highest reliability parameter is the ratio be-
tween the summation potential amplitude and the action 
potential amplitude (SP/AP ratio). In Meniere’s disease, 
the alterations in the physical properties and mechanisms 
of the base membrane, caused by a distention in the scala 
media, cause changes in the electrical responses triggered 
by sound stimuli. As a result, the SP/AP ratio is altered 
because of an increase in SP potential16.
One of the major difficulties in approaching a 
patient with Meniere’s disease has been to establish an 
objective correlation between clinical symptoms, disease 
progression and electrocochleography. Characteristically 
speaking, the disease has periods of remission and exa-
cerbation, with varying vertigo spells duration, intensity 
and frequency. Symptoms may be present together or in 
isolation, especially in the initial disease stages, delaying 
diagnosis and proper treatment. On the other hand, on 
the second decade of progression, vertigo stabilizes, with 
a sensitive reduction in crises periodicity. In prior investi-
gations, some authors have observed that, the longer the 
progression time, the higher is the prevalence of bilateral 
involvement and, consequently, a greater impact on the 
patient’s life quality1. Moreover, progression time seems to 
be related to symptoms severity, shown by patients with 
late development who had hearing loss and less intense 
physical disability when compared to patients with earlier 
onset. 
The goal of the present investigation is to study the 
progression of Meniere’s disease in patients with clinical 
diagnosis established and confirmed by transtympanic 
electrocochleography, in relation to vertigo spells time of 
progression and other symptoms (tinnitus, ear fullness, 
hearing loss) and to age range.
PATIENTS AND METHODS
This is a transversal descriptive retrospective study, 
which was submitted to the Research Ethics Committee of 
the UNIFESP/EPM and was approved according to protocol 
number 1780/06.
54 Meniere’s disease patients were assessed, seen at 
the reference clinic, from February to November of 2005, 
according to the clinical criteria that were proposed and 
revised in 1995, by the AAO-HNS.
15 patients with neurological signs and symptoms, 
otologic diseases, exposure to noise or tympanic mem-
brane (TM) were taken off the study. Thus, 39 patients 
with established clinical diagnosis of unilateral or bilateral 
Meniere’s disease, proven by transtympanic electroco-
chleography (SP/AP ratio ≥ 35%) were included in the 
study.
The patients were submitted to full otorhinolaryn-
gological exam, audiometric evaluation and bilateral trans-
tympanic electrocochleography. After these procedures, 
the patients were divided in 2 groups: Group 1: bilateral 
Meniere’s disease (electrocochleography with a SP/AP ra-
tio ≥ 35% in both ears) and Group 2: unilateral Meniere’s 
disease (electrocochleography with a SP/AP ratio ≥ 35% 
in one single ear).
Initially we carried out a data descriptive analysis. 
The qualitative variables were presented by means of 
absolute frequencies (n) and relative frequencies (%). 
Quantitative variables by mean values, medians, standard 
deviations, maximum and minimum values.
The two groups were compared by means of the 
t Student test for the parametric variables (ages). For the 
non-parametric variables (symptoms progression time and 
spells’ frequency), the Mann-Whitney and the Fisher’s 
exact tests were used. The odds ration (OR) was used 
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as an estimate of the relative risk, with a 95% confidence 
interval. In order to assess possible correlations between 
symptoms progression times, we used the Spearman cor-
relation coefficient. r values between 0.2 and 0.5 indicating 
weak correlation, between 0.5 and 0.7, moderate, and 
greater than 0.8, a strong correlation27. The significance 
level adopted was of 5% (p<0.05).
RESULTS
Of the 39 patients assessed, 31 were females 
(79.5%). Patients’ ages when the symptoms started varied 
between 18 and 72 years, with average age of 42.9 years, 
with standard deviation of 13.3. Nineteen patients (48.7%) 
had between 41 and 64 years of age (Table 1).
Twenty six patients (66.6%) presented with bilateral 
disease, confirmed by transtympanic electrocochleography. 
The age-related evaluation at symptoms onset showed 
that, in the bilateral group, age was lower (33.7 years) 
than in the unilaterally affected patients (47.5 years) (p= 
0.0013, t Student test), according to table 3. By the same 
token, patients’ age at the time of the fist office visit was 
also lower in the bilateral group (43.7) when compared 
to the unilateral group (57.7 years) (p= 0.0018, t Student 
test) (Figure 1).
Table 1. Demographic data of 39 patients with definitive diagnosis of 
Meniere’s disease, proven by transtympanic electrocochleography.
Gender (M/F) 8/31
Age at first consultation* 53.0 13.8
Age of symptoms onset* 42.9 13.3
< 20 years 2 (5.1%)
21- 40 years 16 (41.1%)
41-64 years 19 (48.7%)
>65 years 2 (5.1%)
Legend: * Data expressed in years by means of average standard 
deviation. M: male and F: female.
Progression time median regarding vertigo was of 7 
years, for tinnitus it was of 4 years, for ear fullness 3 years 
and hearing loss, 5.5 years. Of the 33 patients we had data 
on, 18 (54.5%) had hearing fluctuation; and of the 35 who 
had information related to spells periodicity, 23 (65.7%) 
had frequent spells (daily or weekly). The clinical charac-
teristics of the 39 patients are described on Table 2.
Table 2. Auditory and vestibular progression time, expressed in 
years, hearing fluctuation frequency and daily or weekly spells, ex-
pressed in number of episodes, of the 39 patients with a definitive 
clinical diagnosis of Meniere’s disease. 
Vertigo * 7.0 (3.5-15.0)
Tinnitus* 4.0 (2.0-12.0)
Ear fullness* 3.0 (2.0-10.0)
Hearing loss* 5.5 (3.0-12.0)
Hearing fluctuation 18/33
Vertigo spells 23/35
* Data expressed in median and interquartile variation
Table 3. Symptoms onset age and first medical visit, represented in 
years, of the 39 patients with definitive clinical diagnosis of Meniere’s 
disease in both, the unilateral and bilateral involvement groups, 
proven by transtympanic electrocochleography.
 BILATERAL UNILATERAL p
N 13 26  
Men/Women 1/12 7/19 0,23
Symptoms 
onset age*
33.7 11.2 47.5 12.0 0.0013
Age of first 
medical visit*
43.7 11.1 57.7 12.7 0.0018
Legend: * Data expressed in years by mean standard deviation.
Figure 1. Patients’ ages at symptoms onset, expressed in years, by 
medians, interquartile variation and extremes, of the 39 patients with 
definitive clinical diagnosis of Meniere’s disease, with bilateral and uni-
lateral involvement, proven by transtympanic electrocochleography.
Vertigo, tinnitus and hearing loss evolution time 
median was slightly lower in the bilateral group, however 
not reaching statistical significance. There was also no 
difference between the presence of hearing fluctuation 
and frequent vertigo spells (daily or weekly) between the 
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groups analyzed (Tables 4 and 5).
As far as the disease progression time is concerned, 
there were no differences in the prevalence of patients 
with more than 10 years of disease progression between 
the groups: there were 6 patients (46.1%) in the bilateral 
group and 11 (42.3%) in the unilateral group, with odds 
ration (OD) of 1.17 and 95% confidence interval (IC 95%) 
of 0.31 to 4.46.
There was also no difference between the two 
groups as far as progression time above 20 years is con-
cerned: 2 patients (15.4%) in the bilateral group and 5 
(19.2%) in the unilateral group, with OD= 0.26 [IC 95% 
0.03-2.44].
Evaluating the total number of patients, we detected 
a moderate correlation between disease progression time 
and the time of tinnitus occurrence (r= 0.7046). By sepa-
rating the groups we noticed a moderate correlation both 
in bilateral (r= 0.5115) and in unilateral involvement (r= 
0.7715). We observed a weak correlation between disease 
progression time and ear fullness (r= 0.4699). Alone, we 
noticed a weak correlation in both groups (r= 0.3945) for 
the bilateral involvement, and (r= 0.4310) for unilateral. 
There also was a weak correlation between disease pro-
gression time and hearing loss time (r= 0.4859 - Figure 2). 
By the same token, by separating the groups, we noticed 
a weak correlation (r= 0.3899) for bilateral involvement, 
and (r= 0.4753) for unilateral. 
Table 4. Vestibular and auditory symptoms evolution time, expres-
sed in years of the 39 patients with definitive diagnosis of Meniere’s 
disease, proven by transtympanic electrocochleography, according 
to unilateral or bilateral involvement.
 BILATERAL UNILATERAL p
N 13 26  
Vertigo** 5.0 (3.0-17.0) 7.5 (4.0-12.0) 0.79
N 12 25  
Tinnitus** 4.0 (1.9-15.3) 5.0 (3.0-10.0) 0.56
N 10 21  
Ear fullness** 3.5 (1.6-12.5) 3.0 (2.0-10.0) 0.85
N 12 25  
Hearing loss** 4.0 (2.0-16.0) 6.0 (3.0-11.5) 0.75
Table 5. Hearing fluctuation and vertigo spells, expressed in number 
of episodes, of the 39 patients with definitive clinical diagnosis of 
Meniere’s disease, proven by transtympanic electrocochleography, 
according to unilateral or bilateral involvement.
 BILATERAL UNILATERAL p
Hearing fluctu-
ation
5/9 13/24 1,00
Frequency of 
spells
   
Daily 2 7 0,69
Weekly 6 8 0,28
Monthly 1 8 0,21
Annual 2 1 0,23
Figure 2. Correlation between tinnitus progression time and vertigo 
onset, expressed in years, for the 39 patients with definitive clinical 
diagnosis of Meniere’s disease.
DISCUSSION
In this study we observed that, patients with bila-
teral involvement have the disease starting earlier on and 
seek specialized medical advice earlier than those patients 
with unilateral disease. We did not notice differences in 
the other clinical variables analyzed (disease progression 
time, associated symptoms and their characteristics).
A larger prevalence of women (79.5%) was in 
disagreement with what was seen in previous papers18-
22, however it was similar to what was seen by Havia et 
al.23 very likely because more women seek doctors when 
compared to men, in our culture.
We also observed prevalence in individuals on their 
fourth decades of life, and the average age for symptoms 
onset was of 42.9 years, similar to what was seen in other 
studies 23,24.
Time interval between symptoms onset and specia-
lized treatment was greater in our patients (10.1 years), 
comparatively to European studies, which vary between 3, 
4 and 6 years23,24. It is likely that such delay be related to 
our precarious health care system and the lack of patient 
education in our country.
Of all the patients studied, more than half had 
hearing fluctuation and about two thirds complained of 
frequent vertigo spells (daily or weekly), reflecting its 
negative impact on life quality.
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In this sample, by means of the transtympanic 
electrocochleography, we detected bilateral involvement 
in 33.3% of the cases. Other studies showed prevalen-
ces of 35%25 and 53%24 of bilateral cases by means of 
transtympanic electrocochleography. These values may 
vary according to sample size, hearing loss level, disease 
progression time and the patient’s clinical complaints on 
the day of the exam.
It is a consensus among many authors that, the 
longer the disease progression time, the greater is the 
percentage of bilateral involvement18,22-24. We did not ob-
serve associations between disease progression time and 
bilateral involvement, possibly because of the small size 
of our sample.
According to Havia et al., 44% of the patients 
with progression times above 20 years had bilateral 
involvement23. In our study, 7 patients had had symptoms 
for more than 20 years, two of them with bilateral alteration 
seen at the transtympanic electrocochleography. The small 
sample size makes these comparisons very limited.
In Meniere’s disease, vestibular symptoms are not 
necessarily related to cochlear symptoms 20,26. In fact, we 
noticed a weak intensity correlation between vertigo pro-
gression time and hearing loss.
CONCLUSION
Most individuals with Meniere’s disease presented 
symptoms onset after the fourth decade of life. Individuals 
with bilateral involvement presented symptoms earlier on 
when compared to those individuals with unilateral symp-
toms. There were no differences between the bilateral and 
unilateral groups in relation to disease progression and 
associated symptoms.
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